about
Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis.TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.Role of arginase 1 from myeloid cells in th2-dominated lung inflammation.Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.How reliable are sino-nasal cell lines for studying the pathophysiology of chronic rhinosinusitis?Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosisFibrosis is a common outcome following total knee arthroplasty.A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplastyCytokine mediated tissue fibrosisIL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts.Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation.CMT3 alters mitochondrial function in murine osteoclast lineage cells.The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function.TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma.Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response.TNFα from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis.The annexin 2-S100A10 complex and its association with TRPV6 is regulated by cAMP/PKA/CnA in airway and gut epithelia.Airway epithelial cell senescence in the lung allograft
P50
Q34166520-CB9FB086-F321-40FB-8EC5-85E46B666364Q34294635-899884E3-30EC-45B9-AC25-F8407416ABB6Q34700777-6CCACE1C-26D4-44A5-B2F2-390151BDEAF0Q34803336-86E3C86C-8F1E-4878-A5CD-22B65173A8FAQ35578178-364CCF4E-EF5C-4CF4-9480-CDB8120ED651Q36225950-9009A9A5-E5EE-4E9C-8ED5-0E287F11C81EQ36265686-0AD1FB81-7D31-45D0-81B7-84541758C701Q36265733-1D27D5E0-62F5-45B5-88DE-06452F00E14FQ37209512-F282D9E8-F7F0-4F74-B4DF-8CDE469AD698Q37597431-E4F54C8D-E8F5-4A75-A6A2-01FBC64F7E27Q38356658-817F116F-DF8E-4BBD-A89F-339B2D95C765Q40045365-19370313-1EF7-407D-A518-20E65791D46AQ40117334-0EAA98EE-0BFA-4999-8586-9649A36FFDDAQ41042964-DFB0336A-C7EA-433E-93DE-7B9DDD06EF2EQ41916968-D827E282-C9CA-40AF-B531-A56E174F10A4Q41997908-A387808A-87C1-4500-B2B8-4CEA3A431F5BQ46561167-0A019251-723D-426C-B8BF-87018997A4D0Q46814155-F359BFB6-18D8-4A70-826B-C577653B81ECQ81464809-D8344541-84D6-441D-A8B9-67BCEE864689
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lee A Borthwick
@ast
Lee A Borthwick
@en
Lee A Borthwick
@es
Lee A Borthwick
@nl
type
label
Lee A Borthwick
@ast
Lee A Borthwick
@en
Lee A Borthwick
@es
Lee A Borthwick
@nl
prefLabel
Lee A Borthwick
@ast
Lee A Borthwick
@en
Lee A Borthwick
@es
Lee A Borthwick
@nl
P106
P31
P496
0000-0003-2885-3382